Language
English
Publication Date
2-1-2025
Journal
The Journal of the American Academy of Dermatology
DOI
10.1016/j.jdin.2024.09.009
PMID
39719960
PMCID
PMC11667042
PubMedCentral® Posted Date
10-22-2024
PubMedCentral® Full Text Version
Post-print
Abstract
BACKGROUND: Little is known about the dermatologic manifestations of multisystem inflammatory syndrome in children (MIS-C) in children and adolescents.
OBJECTIVE: We sought to describe the demographic background, key clinical features, and the clinical consequences of developing rash manifestations in MIS-C patients at Texas Children's Hospital.
METHODS: Descriptive retrospective cohort study of 290 hospitalized eligible patients between May 2020 and April 2022.
RESULTS: Among MIS-C patients, 51% exhibited a rash. We found that younger children (8.62 vs 9.49 years of age,
LIMITATIONS: Rash characteristics were initially described by a variety of physicians in the pediatric primary care services.
CONCLUSION: Rash manifestations in MIS-C patients are associated with lower cardiac involvement and decreased troponin levels.
Keywords
clinical research, COVID-19, multisystem inflammatory syndrome in children, pediatric dermatology, rash, SARS-CoV-2
Published Open-Access
yes
Recommended Citation
Penna, Matthew; Pupa, Lauren; Lee, Grace; et al., "Skin Manifestations and Related Clinical Characteristics of Multisystem Inflammatory Syndrome in Children: A Descriptive Retrospective Cohort Study at Texas Children’s Hospital" (2025). Faculty and Staff Publications. 3894.
https://digitalcommons.library.tmc.edu/baylor_docs/3894